Triple Anti-Diabetic Tablet Franchise in Ahmedabad

Name: Istalab DM 1000 Tablet (Dapagliflozin 10mg + Metformin 1000mg + Sitagliptin 100mg)
Brand: Istalab DM 1000 Tablet
Rating: 4.8 (150 reviews)

Dapagliflozin Metformin Sitagliptin Tablet Supplier in Mumbai

Blood Sugar Control Tablet Distributor in Delhi

Type 2 Diabetes Combination Tablet Manufacturer in Bangalore

Anti-Diabetic Tablet Stockist in Hyderabad

Dapagliflozin Combination Tablet Exporter in Chandigarh

Home/Products /dapagliflozin-10mg-metformin-1000mg-sitagliptin-100mg-tablet

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Dapagliflozin Metformin Sitagliptin Tablet PCD Supplier

Dapagliflozin 10mg + Metformin 1000mg + Sitagliptin 100mg – PCD Pharma Franchise Marketing Material

Dapagliflozin metformin sitagliptin tablet product video

Triple anti-diabetic tablet literature PDF

Istalab DM 1000 Tablet

Composition : Dapagliflozin (10mg) + Metformin (1000mg) + Sitagliptin (100mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Please Contact For Best Price

Dapagliflozin 10mg + Metformin 1000mg + Sitagliptin 100mg tablet is a triple-action anti-diabetic formulation designed for the effective management of type 2 diabetes mellitus.

Dapagliflozin works by promoting glucose excretion through urine, Metformin reduces hepatic glucose production and improves insulin sensitivity, and Sitagliptin enhances incretin activity to increase insulin release and reduce glucagon levels.

This combination is commonly prescribed for patients requiring intensified glycemic control, including fasting and postprandial blood sugar management, helping reduce long-term diabetic complications.

With comprehensive glucose-lowering action, convenient once-daily dosing, and strong clinical acceptance, this formulation strengthens a diabetes management portfolio and supports consistent demand in advanced anti-diabetic therapy.

About the Product

Dapagliflozin 10mg + Metformin 1000mg + Sitagliptin 100mg tablet is a triple-action anti-diabetic formulation designed for the effective management of type 2 diabetes mellitus.

Common side effects may include nausea, diarrhea, urinary tract infections, increased urination, headache, or hypoglycemia when used with other antidiabetic agents. Rarely, lactic acidosis or ketoacidosis may occur.

Istalab DM 1000 Tablet is indicated for the management of type 2 diabetes mellitus in adults inadequately controlled with diet, exercise, and dual therapy, as prescribed by a healthcare professional.

For oral use only. Use strictly under medical supervision. Take with meals to reduce gastrointestinal discomfort. Regular monitoring of blood glucose, renal function, and hydration status is recommended during therapy.

Store below 25°C in a cool, dry place. Protect from moisture and light. Keep out of reach of children.